Quantification of small RNA presence in <i>Eh</i>A1 and <i>Eh</i>B2 EVs. miRNA sequencing data were annotated according to Zhang et al. [30] reference. by Barbara Honecker (10328267)

Subjects:

Comparison of <i>Eh</i>A1 and <i>Eh</i>B2 trophozoite proteomes. by Barbara Honecker (10328267)

Subjects:

Release of cytokines and myeloperoxidase upon EV stimulation. by Barbara Honecker (10328267)

Subjects:

Secondary antibody controls for immunogold labeling of <i>Eh</i>A1 and <i>Eh</i>B2 EVs. by Barbara Honecker (10328267)

Subjects:

Proteins present in negative controls. by Barbara Honecker (10328267)

Subjects:

Quantification of cytokine and myeloperoxidase release upon EV stimulation. by Barbara Honecker (10328267)

Subjects:

Antimicrobial susceptibility profile of <i>S</i>. <i>aureus</i>. by Mansour Mohamadou (13020837)

Subjects:

Flow cytometry analysis of marker expression on EV-stimulated monocytes. by Barbara Honecker (10328267)

Subjects:

Target prediction of novel <i>E. histolytica</i> miRNAs in the human and <i>E. histolytica</i> genome. by Barbara Honecker (10328267)

Subjects:

Comparison of <i>Eh</i>A1 and <i>Eh</i>B2 EV proteomes. by Barbara Honecker (10328267)

Subjects:

Antimicrobial susceptibility profile of MRSA isolates. by Mansour Mohamadou (13020837)

Subjects:

Prevalence of <i>Staphylococcus aureus</i> among clinical samples collected between April 2019 to December 2020. by Mansour Mohamadou (13020837)

Subjects:

Pathways and interferon-stimulated genes affected by EV stimulation of monocytes. by Barbara Honecker (10328267)

Subjects:

Analysis of novel miRNAs in <i>E. histolytica</i> EVs. by Barbara Honecker (10328267)

Subjects:

Midpoint estimates of resistance parameters. by Kory D. Johnson (12519419)

Subjects:

Average resistance against Delta and the hypothetical variant Omega due to immunity waning in an mRNA-fully-vaccinated population. by Kory D. Johnson (12519419)

Subjects:

Controller with a larger delay leads to significantly more pronounced outbreaks, especially with reactive control. by Kory D. Johnson (12519419)

Subjects:

Reported prevalence of different SARS-CoV-2 variants in Austria in 2021. by Kory D. Johnson (12519419)

Subjects:

Estimate of the population composition in Austria on June 12 and August 8, 2021. by Kory D. Johnson (12519419)

Subjects:

Responding to the effective reproduction number is more efficient than only using case numbers. by Kory D. Johnson (12519419)

Subjects: